tricuspid regurgitation

5 · 20 / page

Ask MedXY AI

Latest news

Tag

MedTechTriCliptricuspid regurgitation

Abbott initiates real-world TriClip postmarket study as Edwards prepares Pascal U.S. launch

By MedXY|Jul 29, 2026

Abbott begins a 1,000-patient postmarket study of its TriClip tricuspid repair device, gathering real-world safety and efficacy data ahead of anticipated U.S. competition from Edwards Lifesciences.

CardiologyCardiologyheart failure

tricuspid regurgitation

Latest news

Abbott initiates real-world TriClip postmarket study as Edwards prepares Pascal U.S. launch

Tricuspid Valve Replacement Outcomes by Baseline Tricuspid Regurgitation Severity: TRISCEND II Trial

GLIDE Score Emerges as a Robust Predictor of Success in Direct Transcatheter Tricuspid Valve Annuloplasty

Redefining Severity in Tricuspid Regurgitation: Why CMR-Derived Regurgitant Fraction and Liver Mapping Are the New Prognostic Gold Standards

Advancements in Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: Insights from the TRILUMINATE Pivotal Trial